Skip to main content
SpringerLink
Log in

Use of BNP Levels in Monitoring Hospitalized Heart Failure Patients with Heart Failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, Hennen J. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99–104.

    Google Scholar 

  2. Konstam MA, Kimmelstiel CD. Economics of heart failure. In: Balady GJ, Pina IL, eds. Exercise and Heart Failure. Armonk, NY: Futura, 1997:19–281. Adams KF. Post hoc subgroup analysis and the truth of a clinical trial. Am Heart J 1998;136:751–758.

    Google Scholar 

  3. Cheng VL, Krishnaswamy P, Kazanegra R, et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure. J Am Coll Cardiol 2001;37:386–391.

    Google Scholar 

  4. Bettencourt P, Ferreira S, Azevedo A, Ferreira A. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcomes after hospital discharge in patients with heart failure. Am J Med 2002;113(3):215–219.

    Google Scholar 

  5. Kazanagra R, Chen V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel AS. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study. J Card Failure 2001;7:21–29.

    Google Scholar 

  6. Maisel A. Algorithms for using B-type natriuretic peptide levels in the diagnosis and management of congestive heart failure. Critical Pathways in Card 2002;1(2):67–73.

    Google Scholar 

  7. Sodian R, Loebe M, Schmitt C, Potapov EV, Siniawski H, Muller J, Hausmann H, Zurbruegg HR, Weng Y, Hetzer R. Decreased plasma concentrations of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiology 2001;38:1942–1949.

    Google Scholar 

  8. Abraham WT, Lows BD, Ferguson DA, Odom J, Kim JK, Robertson AD, Bristow MR, Schrier RW. Systemic hemodynamic, neurohormonal, and renal effects of a steadystate infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Cardiac Failure 1998;4(1):37–44.

    Google Scholar 

  9. Publication Committee for the VMAC Investigators. Intravenous nesiritide versus nitroglycerin for the treatment of decompensated congestive heart failure—A randomized controlled trial. JAMA 2002;287(12):1531–1540.

    Google Scholar 

  10. Fonarow GC. Pharmacologic therapies for acutely decompensated heart failure. Reviews in Cardiovasc Med 2002;3(Suppl 4):S18–S27.

    Google Scholar 

  11. Emerman CL. Safety and efficacy of nesiritide for the treatment of decompensated heart failure. Reviews in Cardiovasc Med 2002;3(Suppl 4):S28–S34.

    Google Scholar 

  12. BergerCirculation 2002;105:2392–2397.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Medicine, San Diego VA Healthcare System and University of California, San Diego, CA, USA

    Alan S. Maisel

Authors
  1. Alan S. Maisel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan S. Maisel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maisel, A.S. Use of BNP Levels in Monitoring Hospitalized Heart Failure Patients with Heart Failure. Heart Fail Rev 8, 339–344 (2003). https://doi.org/10.1023/A:1026139130208

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026139130208

Keywords

Search

Navigation